DV
Dividend Vision

QURE — uniQure N.V.

uniQure N.V. (QURE)

Total return is 232.8% over the past 12.5 years, 214.2 points behind SPY at 447.0%. Its deepest 1-year drawdown was 87.2%.

QURE is a single-stock equity fund that tracks uniQure N.V., a gene therapy company. The fund does not currently distribute dividends, reflected in its N/A distribution rate, and provides no yield income to shareholders. This fund appeals primarily to investors seeking exposure to a specific biotechnology company rather than those pursuing dividend income strategies.

QURE key facts

Asset type
Stock
Asset class
Equity
Inception date
02/05/2014
Distribution frequency
None
Last close
$48.62
Market cap
$3,372,594,944
Average volume
956500.0
Beta
0.94
Payout ratio
0.0
Forward P/E
27.933
EPS
$-4.20